The research also found the hazard risk of #suicide was highest across all cohorts within a year of diagnosis or initial treatment
GlobalData HealthcareThe research also found the hazard risk of #suicide was highest across all cohorts within a year of diagnosis or initial treatment.
As the #stigma surrounding #mentalhealth continues to diminish, #healthprofessionals have begun to shed light on the risk of #suicide. Among the populations considered in this trend are individuals with terminal illnesses, who are the focus of a recent publication in The Lancet, by Nafilyan and colleagues. This population-based study, which explored the relationship between terminal illness diagnosis dates and #patient #suiciderates in England, revealed that individuals diagnosed with conditions with a high risk of death faced an increased risk of #suicide. Moreover, the hazard risk of #suicide was highest across all cohorts within a year of diagnosis or initial treatment. GlobalData epidemiologists forecast a rise in the prevalence of several of the diseases observed in the study across the 16MM (the US, France, Germany, Italy, Spain, the UK, Japan, Australia, Brazil, Canada, China, India, Mexico, Russia, South Africa, and South Korea), underscoring the need for a comprehensive understanding of terminal disease #patients’ #mentalhealth.
#James Donaldson notes:
Welcome to the “next chapter” of my life… being a voice and an advocate for #mentalhealthawarenessandsuicideprevention, especially pertaining to our younger generation of students and student-athletes.
Getting men to speak up and reach out for help and assistance is one of my passions. Us men need to not suffer in silence or drown our sorrows in alcohol, hang out at bars and strip joints, or get involved with drug use.
Having gone through a recent bout of #depression and #suicidalthoughts myself, I realize now, that I can make a huge difference in the lives of so many by sharing my story, and by sharing various resources I come across as I work in this space. #http://bit.ly/JamesMentalHealthArticle
Order your copy of James Donaldson’s latest book,
#CelebratingYourGiftofLife:
From The Verge of Suicide to a Life of Purpose and Joywww.celebratingyourgiftoflife.com
Nafilyan and colleagues conducted a retrospective cohort study using the Hospital Episode Statistics (HES) entries and death registration records for 47,354,696 individuals between 2017–2021. Deaths caused by intentional #self-harm were linked to health records showing first diagnoses of low-survival cancers, chronic obstructive pulmonary disease (COPD), degenerative neurological diseases (i.e., Huntington’s and motor neuron diseases), and chronic ischemic heart disease. The entire study population, including those without terminal illnesses, showed a #suicide incidence rate (defined as suicides per 100,000 population) of 36.3. While individuals with a low-survival cancer or chronic ischemic heart disease diagnosis showed a slightly lower incidence of #suicide at 32.8 and 33.6, respectively. Conversely, the #suicide incidence was 51.4 among those diagnosed with COPD and 126.0 among those diagnosed with degenerative neurological conditions. Furthermore, the rate of #suicide in these groups was particularly high in the first few months following diagnosis. For example, the rate of #suicide six months following diagnosis was 16.6 among low-survival cancer #patient compared to 5.7 in the control group. This rate rose to 21.6 one year after diagnosis compared to 9.5 in the control group. Throughout the study period, the hazard rate of death due to #suicide was higher among all groups diagnosed with a terminal illness than their matched controls, with a spike in the first months followed by a stabilizing but elevated rate thereafter.
The results of Nafilyan and colleagues’ study sheds a light on severe #mentalhealth toll exacted upon #patients with terminal diseases. GlobalData epidemiologists project that the diagnosed prevalent cases of several terminal illnesses are expected to rise over the next decade. Diagnosed prevalent cases of COPD are expected to grow from almost 115.1 million to approximately 141.5 million between 2018 and 2028 in the 16MM. Similarly, there is an expected rise in the diagnosed prevalent cases of Huntington’s disease, exceeding 125,000 in 2020 and increasing to over 135,000 cases in 2030 across the 16MM. The growing burden of terminal diseases necessitates counseling and support networks for affected #patients. Furthermore, Nafilyan and colleagues’ work emphasizes the importance of intensive monitoring for signs of #suicidalideation in the earliest months of diagnosis.
James Donaldson is a Washington State University graduate (’79). After an outstanding basketball career with WSU, he went on to play professional basketball in the NBA with the Seattle Supersonics, San Diego/L.A. Clippers, Dallas Mavericks, New York Knicks, and Utah Jazz. He also played for several teams in the European Leagues in Spain, Italy, and Greece, and he toured with The Harlem Globetrotters to wrap up his career. James was an NBA All-Star in 1988 while playing center for the Dallas Mavericks. In 2006, James was inducted into the Pac-10 Sports Hall of Fame and also the Washington State University Athletic Hall of Fame. In 2010, James was elected as a board member for the NBA Retired Players Association.
James frequently conducts speaking engagements (motivational, inspirational, educational) for organizations, schools, and youth groups.
In 2010, James was the recipient of the NBA Legends of Basketball ABC Award, awarded for outstanding contributions in Athletics–Business–Community.
He believes in being a role model for success and professionalism to the scores of young people to whom he devotes so much of his time. He currently serves on several boards and committees and is a member of many organizations.
James believes in developing relationships that create a “Win-Win” environment for everyone involved, and in being the best he can be!
For more information about James Donaldson or to request he speak at your event, contact him at:
www.StandingAboveTheCrowd.com
JamesD@StandingAboveTheCrowd.com
1-800-745-3161 (voicemail & fax)
James Donaldson is the author of “Standing Above The Crowd” and “Celebrating Your Gift of Life” and founder of the Your Gift of Life Foundation which focuses on mental health awareness and suicide prevention, especially pertaining to our school aged children and men.
If you’re interested in having James come and speak to your group of young adults, business entrepreneurs, aspiring political and community leaders, and athletic teams, please contact him at jamesd@yourgiftoflife.org and or leave a personal message for him at 1-800-745-3161. Keep up with him and read about how he is reaching out and making a difference in the lives of so many around the world at www.yourgiftoflife.org